Market Overview:
The global drug safety and pharmacovigilance (PV) software market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing number of clinical trials, growing demand for cloud-based PV software, and rising awareness about drug safety and pharmacovigilance. On the basis of type, the global PV software market is segmented into on-premises PV software and cloud-based PV software. The on-premises PV software segment is expected to dominate the market in 2018 owing to its advantages such as low cost and better security features as compared to cloud-based PV software. However, the cloud-based PV Software segment is projected to grow at a higher CAGR during the forecast period due its advantages such as scalability, lower TCO (total cost of ownership), faster deployment time, and easy access from anywhere across the globe. Based on application, Pharma & biotech companies accounted for majority share in 2017 owing high adoption rate by these companies for managing their large pool of data related with drugs & clinical trials followed by CROs which are witnessing highest growth rate due increased outsourcing by pharma & biotech companies for conducting various phases Clinical Trials .
 Software Industry Outlook.svg)
Product Definition:
Drug Safety and Pharmacovigilance (PV) Software is a software system used to collect, store, track and analyze data on the safety of drugs. It is used to help ensure that the benefits of drug therapies outweigh their risks.
On-Premises:
On-premises PV software is a standalone system that has its own dedicated hardware. It's an independent system, which means it has all the necessary components to run and perform its tasks independently from the cloud or internet.
The growth of on-premises PV software can be attributed to factors such as high data security than cloud based systems, easy retrieval of lost or stolen devices as against cloud based solutions and no third party access to information stored in the database unlike other solutions.
Cloud-Based:
Cloud-based pharmacovigilance software is a type of electronic PV system that enables remote access to clinical data and information. It provides real-time safety assurance by facilitating the integration of new data with existing records in a secure database. Cloud-based pharmacovigilance software offers benefits such as easy accessibility, reduced labor cost, and enhanced efficiency which are expected to drive the market during the forecast period.
Application Insights:
The global market is segmented by application into the company, contract research organizations (CROs), business process outsourcing (BPO) firms and others. The company application segment dominated the overall market in 2017 and is expected to witness a CAGR of XX% from 2018 to 2030. This growth can be attributed to increasing demand for drug safety & pharmacovigilance software by companies operating in various industries such as healthcare, life sciences, manufacturing and IT across the globe.
The CRO segment was estimated at USD 120 million in 2017 owing to high usage of these applications by biopharmaceutical companies for various purposes such as generating reports on clinical trials activities globally.
Regional Analysis:
Asia Pacific region is anticipated to witness the highest CAGR over the forecast period owing to increasing drug development activities in this region. The presence of a large number of CROs and BPOs also contributes towards regional growth. Furthermore, Asia Pacific has several emerging economies such as China and India that are among the top 10 global pharmaceutical markets. These factors are expected to drive regional demand for PV software during the forecast period.
North America held a substantial revenue share in 2017 due to high adoption of drug safety systems by major companies operating within this region coupled with growing government initiatives pertaining toward PV implementation across various industries including healthcare & life sciences, food & beverage, manufacturing sector etc., which is further expected fuel market growth over next eight years.
The European market was valued at USD X million in 2017.
Growth Factors:
- Increasing demand for safe and effective drugs
- Growing number of clinical trials
- Stringent regulatory requirements for drug safety and pharmacovigilance
- Rising incidence of adverse drug reactions (ADRs)
- Proliferation of digital technologies
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Safety and Pharmacovigilance (PV) Software Market Research Report
By Type
On-Premises, Cloud-Based
By Application
Pharma and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Other
By Companies
ArisGlobal (US), Ennov Solutions Inc. (US), EXTEDO GmbH (US), Online Business Applications, Inc. (US), Oracle Corporation (US), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (US), United BioSource Corporation (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
177
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Drug Safety and Pharmacovigilance (PV) Software Market Report Segments:
The global Drug Safety and Pharmacovigilance (PV) Software market is segmented on the basis of:
Types
On-Premises, Cloud-Based
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharma and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ArisGlobal (US)
- Ennov Solutions Inc. (US)
- EXTEDO GmbH (US)
- Online Business Applications, Inc. (US)
- Oracle Corporation (US)
- Sarjen Systems Pvt. Ltd (India)
- Sparta Systems, Inc. (US)
- United BioSource Corporation (US)
 Software Market Overview.svg)
Highlights of The Drug Safety and Pharmacovigilance (PV) Software Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- On-Premises
- Cloud-Based
- By Application:
- Pharma and Biotech Companies
- Contract Research Organizations (CROs)
- Business Process Outsourcing (BPO) Firms
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Safety and Pharmacovigilance (PV) Software Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Software Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug safety and pharmacovigilance software is a type of software that helps organizations monitor the safety and efficacy of drugs. It can help identify potential drug interactions, adverse effects, and other risks associated with medications. Drug safety and pharmacovigilance software can also help identify potential problems with drug manufacturing or distribution processes.
Some of the major companies in the drug safety and pharmacovigilance (pv) software market are ArisGlobal (US), Ennov Solutions Inc. (US), EXTEDO GmbH (US), Online Business Applications, Inc. (US), Oracle Corporation (US), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (US), United BioSource Corporation (US).
The drug safety and pharmacovigilance (pv) software market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Safety and Pharmacovigilance (PV) Software Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Safety and Pharmacovigilance (PV) Software Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Safety and Pharmacovigilance (PV) Software Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Safety and Pharmacovigilance (PV) Software Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Safety and Pharmacovigilance (PV) Software Market Size & Forecast, 2018-2028
4.5.1 Drug Safety and Pharmacovigilance (PV) Software Market Size and Y-o-Y Growth
4.5.2 Drug Safety and Pharmacovigilance (PV) Software Market Absolute $ Opportunity
Chapter 5 Global Drug Safety and Pharmacovigilance (PV) Software Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Type
5.2.1 On-Premises
5.2.2 Cloud-Based
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drug Safety and Pharmacovigilance (PV) Software Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Applications
6.2.1 Pharma and Biotech Companies
6.2.2 Contract Research Organizations (CROs)
6.2.3 Business Process Outsourcing (BPO) Firms
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Safety and Pharmacovigilance (PV) Software Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drug Safety and Pharmacovigilance (PV) Software Analysis and Forecast
9.1 Introduction
9.2 North America Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Type
9.6.1 On-Premises
9.6.2 Cloud-Based
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Applications
9.10.1 Pharma and Biotech Companies
9.10.2 Contract Research Organizations (CROs)
9.10.3 Business Process Outsourcing (BPO) Firms
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drug Safety and Pharmacovigilance (PV) Software Analysis and Forecast
10.1 Introduction
10.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Type
10.6.1 On-Premises
10.6.2 Cloud-Based
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Applications
10.10.1 Pharma and Biotech Companies
10.10.2 Contract Research Organizations (CROs)
10.10.3 Business Process Outsourcing (BPO) Firms
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drug Safety and Pharmacovigilance (PV) Software Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Type
11.6.1 On-Premises
11.6.2 Cloud-Based
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Applications
11.10.1 Pharma and Biotech Companies
11.10.2 Contract Research Organizations (CROs)
11.10.3 Business Process Outsourcing (BPO) Firms
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drug Safety and Pharmacovigilance (PV) Software Analysis and Forecast
12.1 Introduction
12.2 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Type
12.6.1 On-Premises
12.6.2 Cloud-Based
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Applications
12.10.1 Pharma and Biotech Companies
12.10.2 Contract Research Organizations (CROs)
12.10.3 Business Process Outsourcing (BPO) Firms
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drug Safety and Pharmacovigilance (PV) Software Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Type
13.6.1 On-Premises
13.6.2 Cloud-Based
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Applications
13.10.1 Pharma and Biotech Companies
13.10.2 Contract Research Organizations (CROs)
13.10.3 Business Process Outsourcing (BPO) Firms
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Safety and Pharmacovigilance (PV) Software Market: Competitive Dashboard
14.2 Global Drug Safety and Pharmacovigilance (PV) Software Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ArisGlobal (US)
14.3.2 Ennov Solutions Inc. (US)
14.3.3 EXTEDO GmbH (US)
14.3.4 Online Business Applications, Inc. (US)
14.3.5 Oracle Corporation (US)
14.3.6 Sarjen Systems Pvt. Ltd (India)
14.3.7 Sparta Systems, Inc. (US)
14.3.8 United BioSource Corporation (US)
